All In Biotech

Drug Trial Radar · NCT07269210

A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3561774 (Solbinsiran) in Adults With Severe Hypertriglyceridemia

Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Dec 8, 2025

Primary completion

Mar 2027

Study completion Aug 2027

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Dec 8, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and efficacy of solbinsiran in lowering triglycerides and other lipid measures compared to placebo in participants with severe hypertriglyceridemia. Participants will receive two subcutaneous injections.

Conditions

  • Severe Hypertriglyceridemia

Interventions

  • SolbinsiranDrug

    Administered SC

  • PlaceboDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in TriglyceridesTime frame: Baseline, Weeks 16-24 (Time-Average)

Locations

41 sites in 4 countries. Site status is shown where the registry gives one.

  • Onyx Clinical Research

    Phoenix, Arizona · Completed

  • Synexus Clinical Research US, Inc./Orange Grove Family Practice

    Tucson, Arizona · Completed

  • National Heart Institute

    Beverly Hills, California · Completed

  • Ark Clinical Research

    Long Beach, California · Active not recruiting

  • Catalina Research Institute, LLC

    Montclair, California · Active not recruiting

  • Valley Clinical Trials, LLC dba Flourish Research

    Northridge, California · Active not recruiting

  • CMR of Greater New Haven, LLC

    Hamden, Connecticut · Completed

  • Northeast Research Institute - Downtown Office

    Jacksonville, Florida · Active not recruiting

  • Novera Clinical Research

    Miami, Florida · Active not recruiting

  • Inpatient Research Clinic

    Miami Lakes, Florida · Active not recruiting

  • Clinical Site Partners, LLC dba Flourish Research

    Winter Park, Florida · Completed

  • Great Lakes Clinical Trials - Ravenswood

    Chicago, Illinois · Active not recruiting

  • Investigators Research Group

    Brownsburg, Indiana · Active not recruiting

  • Saint Elizabeth Healthcare - Saint Elizabeth Covington Hospital

    Covington, Kentucky · Active not recruiting

  • Flourish Research - Bowie

    Bowie, Maryland · Completed

  • University of Massachusetts Chan Medical School

    Worcester, Massachusetts · Completed

  • AB Clinical Trials

    Las Vegas, Nevada · Completed

  • Clinical Research of Philadelphia

    Pennington, New Jersey · Active not recruiting

  • Weill Cornell Medical College

    New York, New York · Completed

  • Icahn School of Medicine at Mount Sinai

    New York, New York · Active not recruiting

  • Cardiovascular Specialists of Willowbrook

    Houston, Texas · Active not recruiting

  • Southern Endocrinology Associates

    Mesquite, Texas · Active not recruiting

  • American Research Corporation at Texas Liver Institute

    San Antonio, Texas · Completed

  • Endeavor Clinical Trials

    San Antonio, Texas · Completed

  • Stroobants Cardiovascular Center

    Lynchburg, Virginia · Completed

  • TPMG (Tidewater Physicians Multispecialty Group) Clinical Research

    Newport News, Virginia · Active not recruiting

  • Carilion Clinic

    Roanoke, Virginia · Active not recruiting

  • Eastside Research Associates

    Redmond, Washington · Active not recruiting

  • UW Medicine Diabetes Institute

    Seattle, Washington · Active not recruiting

  • Ecogene-21

    Chicoutimi, Canada · Recruiting

  • C.I.C. Mauricie inc.

    Trois-Rivières, Canada · Recruiting

  • ARC Biosystems

    Vancouver, Canada · Recruiting

  • Peking University Third Hospital

    Beijing, China · Recruiting

  • Sichuan Provincial People's Hospital

    Chengdu, China · Active not recruiting

  • Guangdong Provincial People's Hospital

    Guangzhou, China · Active not recruiting

  • The First Affiliated Hospital of Henan University of Science &Technology

    Luoyang, China · Recruiting

  • Zhongshan Hospital,Fudan University

    Shanghai, China · Active not recruiting

  • The Affiliated Hospital of Xuzhou Medical College

    Xuzhou, China · Recruiting

  • The Institute of Medical Science, Asahi Life Foundation

    Chūōku, Japan · Active not recruiting

  • Takai Internal Medicine Clinic

    Kamakura-shi, Japan · Active not recruiting

Showing 40 of 41 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.